Indiscriminate inhibition of multiple DGK isoforms might lead to detrimental outcomes, such as compromised CD8 T cell responses (this study), T cell developmental blockade in the thymus [58], and multi-organ autoimmune diseases (manuscript in preparation). This evidence concerns the gene CD8A and autoimmune disease.